je.st
news
One Internist's Glance At MannKind's Afrezza
2015-01-03 19:28:42| Biotech - Topix.net
I wanted to offer my assessment of the utility of Afrezza as a clinician, after doing a review of some of the available clinical data and evidence. A small meta-analysis of open-label randomized controlled trials from ClinicalTrials.gov indicates that Afrezza was associated with smaller reductions in A1C than control, and higher discontinuation rates.
Tags: glance
afrezza
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||